arrow
M

Mahnaz Shekari

pasqual maragall foundation
H指数:24
被引数:2,916

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regional amyloid accumulation, post-traumatic distress, and intrusive symptoms in cognitively unimpaired older adults at risk for Alzheimer's

认知功能正常的阿尔茨海默病风险老年人群的区域性淀粉样蛋白积累、创伤后痛苦和闯入性症状

2026-09-010
OAAI
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges
2025-12-220
OAAI
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning

认知功能完好个体的皮质厚度亚型:皮质变薄的不同网络和转录组易损性

2025-10-140
OAAI
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

数据驱动的CSF生物标志物分析: 阿尔茨海默病风险队列的成像和临床结果

2024-12-230
OAAI
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease
2024-12-130
OAAI
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity
2024-07-090
OAAI
Amyloid-PET imaging predicts functional decline in clinically normal individuals
2024-06-170
OAAI
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study

调查可靠的淀粉样蛋白在类中的积累: AMYPAD预后和自然史研究的结果

2024-04-044
OA
The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study
2024-04-014
OA
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression

星形胶质细胞生物标志物GFAP和YKL-40介导早期阿尔茨海默病进展

2023-09-1021
OA
Genetic, vascular, and amyloid components of cerebral blood flow in a preclinical population

临床前人群中脑血流的遗传,血管和淀粉样蛋白成分

2023-05-265
OAAI
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sex
2023-04-1721
OA
APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
2023-03-012
OAAI
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease (Sep, 10.1038/s41591-022-01925-w, 2022)
2022-09-135
OAAI